Breaking News Instant updates and real-time market news.

TNDM

TNDM

17:01
10/12/18
10/12
17:01
10/12/18
17:01

Tandem Diabetes receives Health Canada approval to market t:slim X2 insulin pump

Tandem Diabetes Care announced that it has received a Heath Canada Medical Device License for the t:slim X2 Insulin Pump. The t:slim X2 Pump features Dexcom G5 Mobile CGM integration, making it the only CGM-integrated insulin pump approved in Canada for making daily diabetes treatment decisions without fingersticks. The company plans to launch the t:slim X2 Insulin Pump on a province-by-province basis throughout the fourth quarter of 2018 pending the completion of pre-launch activities, including product registration with provincial health programs. The simple-to-use t:slim X2 Insulin Pump includes advanced features like a large color touchscreen, rechargeable battery, USB connectivity and watertight construction. As the only insulin pump integrated with Dexcom G5 Mobile CGM, dynamic glucose data can be easily accessed and shared using a compatible mobile device. The t:slim X2 Pump is up to 38% smaller than other insulin pumps and holds up to 300 units of insulin.

  • 27

    Nov

TNDM TNDM

09/20/18
09/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Westport (WPRT) initiated with a Buy at H.C. Wainwright. 2. Legacy Reserves (LGCY) initiated with a Neutral at Seaport Global. 3. Tandem Diabetes (TNDM) initiated with a Buy at Craig-Hallum. 4. Bio-Rad (BIO) initiated with an Equal Weight at Morgan Stanley. 5. Brookfield (BAM) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/25/18
BARD
09/25/18
NO CHANGE
Target $47
BARD
Neutral
Baird not surprised by upside pre-announcement from Tandem Diabetes
After Tandem Diabetes pre-announced better than expected Q3 revenue and an updated full-year view that implies Q4 revenue largely in line with consensus estimates, Baird analyst Jeff Johnson said he was not surprised by the upside and expects the company's solid fundamentals to persist as U.S. growth remains strong and international revenue starts to contribute. However, he thinks the current valuation reflects this strength and maintains a Neutral rating and $47 price target on Tandem Diabetes shares.
09/26/18
PIPR
09/26/18
NO CHANGE
Target $56
PIPR
Overweight
Tandem Diabetes price target raised to $56 from $32 at Piper Jaffray
Piper Jaffray analyst JP McKim raised his price target for Tandem Diabetes to $56 following the company's "positive" analyst day. The analyst has confidence in above average growth over the next 12 months and sees "lots of room" for estimates to go higher. The shares need to be owned during this "Goldilocks Period" where the company has the best closed loop system on the market, McKim tells investors in a research note. He reiterates an Overweight rating on Tandem Diabetes.
09/26/18
CHLM
09/26/18
NO CHANGE
Target $59
CHLM
Buy
Tandem Diabetes price target raised to $59 from $52 at Craig-Hallum
Craig-Hallum analyst Alexander Nowak raised his price target for Tandem Diabetes to $59 from $52 after a "strong" investor event where the company beat Q3 sales estimates, raised 2018 guidance and announced solid long-term financial figures. Nowak argues that the analyst day confirms his thesis that the company with the best automation and most discreet pump will win, leading to market share gains and accelerated pump therapy penetration. He believes Tandem's story has just begun and is poised to morph into a much larger company as it executes on making diabetes therapy invisible. The analyst reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

IWM

iShares Trust Russell 2000 Index Fund

$153.34

-1.625 (-1.05%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:44
10/19/18
10/19
15:44
10/19/18
15:44
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) at…

IWM

iShares Trust Russell 2000 Index Fund

$153.34

-1.625 (-1.05%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$14.69

0.125 (0.86%)

15:40
10/19/18
10/19
15:40
10/19/18
15:40
Options
Call buyers in US Oil Fund as crude oil ticks higher »

Call buyers in US Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCHP

Microchip

$67.36

-0.18 (-0.27%)

15:35
10/19/18
10/19
15:35
10/19/18
15:35
Options
Microchip put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

15:20
10/19/18
10/19
15:20
10/19/18
15:20
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CLF

Cleveland-Cliffs

$10.92

-0.55 (-4.80%)

15:18
10/19/18
10/19
15:18
10/19/18
15:18
Hot Stocks
Breaking Hot Stocks news story on Cleveland-Cliffs »

Cleveland-Cliffs says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CLF

Cleveland-Cliffs

$10.86

-0.61 (-5.32%)

15:17
10/19/18
10/19
15:17
10/19/18
15:17
Hot Stocks
Breaking Hot Stocks news story on Cleveland-Cliffs »

Cleveland-Cliffs CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/19/18
10/19
15:17
10/19/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRX

AcelRx

$3.77

-0.38 (-9.16%)

15:16
10/19/18
10/19
15:16
10/19/18
15:16
Hot Stocks
AcelRx responds to FDA advisory committee opinions on Dsuvia »

In response to opinions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CLF

Cleveland-Cliffs

$10.89

-0.58 (-5.06%)

15:16
10/19/18
10/19
15:16
10/19/18
15:16
Hot Stocks
Cleveland-Cliffs CEO, after berating analysts, says would handle call same way »

Cleveland-Cliffs CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/19/18
10/19
15:16
10/19/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$127.73

-6.91 (-5.13%)

, STMP

Stamps.com

$194.61

-3.18 (-1.61%)

15:08
10/19/18
10/19
15:08
10/19/18
15:08
OnTheFly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

SHOP

Shopify

$127.73

-6.91 (-5.13%)

STMP

Stamps.com

$194.61

-3.18 (-1.61%)

BLK

BlackRock

$402.46

2.59 (0.65%)

BX

Blackstone

$34.82

-0.45 (-1.28%)

JPM

JPMorgan

$108.18

0.05 (0.05%)

F

Ford

$8.45

-0.055 (-0.65%)

GS

Goldman Sachs

$227.49

2.55 (1.13%)

GOOGL

Alphabet Class A

$1,104.29

7.06 (0.64%)

GOOG

Alphabet

$1,095.63

7.73 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 07

    Nov

  • 13

    Nov

  • 13

    Dec

  • 26

    Feb

  • 03

    Mar

ET

Energy Transfer LP

$17.01

0.19 (1.13%)

15:04
10/19/18
10/19
15:04
10/19/18
15:04
Hot Stocks
Energy Transfer LP: Binding Expansion Open Season for Bakken Pipeline System »

Energy Transfer LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$37.87

-0.12 (-0.32%)

15:00
10/19/18
10/19
15:00
10/19/18
15:00
Options
Active trading in Halliburton ahead of earnings »

Active trading in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FXI

iShares China Large-Cap ETF

$39.39

0.7 (1.81%)

14:50
10/19/18
10/19
14:50
10/19/18
14:50
Options
32K iShares Large Cap China Fund Dec 42 - 44 call spreads trade for 40c »

32K iShares Large Cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEVO

Gevo

$3.61

-0.08 (-2.17%)

, GPRE

Green Plains

$17.97

-0.38 (-2.07%)

14:48
10/19/18
10/19
14:48
10/19/18
14:48
Periodicals
Marathon weighs sale of high-ethanol gas in Minnesota, Bloomberg says »

Marathon Petroleum (MPC)…

GEVO

Gevo

$3.61

-0.08 (-2.17%)

GPRE

Green Plains

$17.97

-0.38 (-2.07%)

PEIX

Pacific Ethanol

$2.03

-0.12 (-5.58%)

MPC

Marathon Petroleum

$74.24

-4.6 (-5.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

CMCSA

Comcast

$35.94

-0.01 (-0.03%)

, CMCSK

Comcast

$0.00

(0.00%)

14:46
10/19/18
10/19
14:46
10/19/18
14:46
OnTheFly
Box Office Battle: 'Halloween' opening to add to massive October »

Comcast (CMCSA, CMCSK)…

CMCSA

Comcast

$35.94

-0.01 (-0.03%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$55.76

-0.28 (-0.50%)

T

AT&T

$32.84

0.34 (1.05%)

FOX

21st Century Fox

$45.33

-0.13 (-0.29%)

FOXA

21st Century Fox

$45.62

-0.19 (-0.41%)

DIS

Disney

$118.42

2.16 (1.86%)

LGF.A

Lionsgate

$22.17

-0.03 (-0.14%)

LGF.B

Lionsgate

$20.72

-0.06 (-0.29%)

VIA

Viacom

$36.75

-0.48 (-1.29%)

VIAB

Viacom

$33.30

-0.43 (-1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

FOSL

Fossil

$19.00

-0.13 (-0.68%)

14:40
10/19/18
10/19
14:40
10/19/18
14:40
Options
Far upside call buying in Fossil »

Far upside call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.67

-1.28 (-0.83%)

, GOOG

Alphabet

$1,090.00

2.1 (0.19%)

14:33
10/19/18
10/19
14:33
10/19/18
14:33
Hot Stocks
#SocialStocks: Snap may be small enough to be acquired, YouTube suffers blackout »

Welcome to…

FB

Facebook

$153.67

-1.28 (-0.83%)

GOOG

Alphabet

$1,090.00

2.1 (0.19%)

GOOGL

Alphabet Class A

$1,098.63

1.4 (0.13%)

TWTR

Twitter

$28.71

-0.58 (-1.98%)

SNAP

Snap

$6.75

-0.06 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 03

    Mar

ABBV

AbbVie

$88.84

-1.1 (-1.22%)

14:22
10/19/18
10/19
14:22
10/19/18
14:22
Recommendations
AbbVie analyst commentary  »

AbbVie's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 02

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/19/18
10/19
14:17
10/19/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/19/18
10/19
14:16
10/19/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPC

Marathon Petroleum

$74.58

-4.26 (-5.40%)

, PEIX

Pacific Ethanol

$1.98

-0.17 (-7.91%)

14:15
10/19/18
10/19
14:15
10/19/18
14:15
Periodicals
Marathon weighs sale of high-ethanol gas in Minnesota, Bloomberg says »

Companies levered to…

MPC

Marathon Petroleum

$74.58

-4.26 (-5.40%)

PEIX

Pacific Ethanol

$1.98

-0.17 (-7.91%)

GPRE

Green Plains

$17.91

-0.44 (-2.40%)

GEVO

Gevo

$3.61

-0.08 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

DHI

D.R. Horton

$35.98

-1.41 (-3.77%)

14:15
10/19/18
10/19
14:15
10/19/18
14:15
Options
D R Horton put volume heavy and directionally bearish »

Bearish flow noted in D R…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

ABBV

AbbVie

$89.28

-0.66 (-0.73%)

14:11
10/19/18
10/19
14:11
10/19/18
14:11
Hot Stocks
AbbVie CFO to retire in mid-2019 »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 02

    Nov

CP

Canadian Pacific

$200.85

1.58 (0.79%)

14:06
10/19/18
10/19
14:06
10/19/18
14:06
Hot Stocks
Canadian Pacific reports Toronto Stock Exchange acceptance of buyback plan »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.